CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.
This review article highlights the transformative potential of in vivo CAR T cell therapy in addressing the limitations of traditional CAR T cell production. This innovative approach could ...
The joint venture of Paccar, Daimler Trucks & Buses and Cummins’ Accelera unit cited weak demand for battery-electric trucks, reduced infrastructure funding and a freight recession for the shift.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback